Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 12, Number 6, December 2021, pages 335-339


Effect of Statin Treatment in Patients With Advanced Carotid Atherosclerosis: An Observational Outcome Study

Figure

Figure 1.
Figure 1. Unadjusted HRs for primary outcome (all events) associated with advanced atherosclerosis on carotid artery (type III-IV b finding) as a function of statin use. HR: hazard ratio. P < 0.0001

Table

Table 1. Baseline Characteristics of All Subjects With Type III and IV b Finding in Ultrasound
 
CharacteristicsType III, IV b (n = 260) with statin therapyType III, IV b (n = 339) without statin therapyP value
BMI: body mass index; LDL: low-density lipoprotein; HDL: high-density lipoprotein; PROCAM: Prospective Cardiovascular Munster Study for Fatal and Non-Fatal Myocardial Infarction; SD: standard deviation.
Age (years), mean ± SD55 ± 654 ± 60.0384
BMI (kg/m2), mean ± SD27.58 ± 4.7127.15 ± 4.000.4731
Smoker, n (%)100 (38.5%)146 (43.1%)0.256
LDL-cholesterol, mean ± SD162 ± 48157 ± 340.4562
HDL-cholesterol, mean ± SD52 ± 1351 ± 130.2445
Triglyceride, mean ± SD176 ± 113176 ± 1070.8166
Systolic blood pressure (mm Hg), mean ± SD133 ± 18133 ± 190.9807
Diastolic blood pressure (mm Hg), mean ± SD82 ± 983 ± 110.1644
Diabetes, n (%)29 (11.1%)21 (6.2%)0.0296
Treated blood pressure (mm Hg), n (%)122 (46.9%)108 (31.9%)0.0002
Positive family history, n (%)87 (33.5%)101 (29.8%)0.3786
Total plaque area (mm2), mean ± SD143 ± 63140 ± 610.407
Maximum plaque thickness (mm), mean ± SD3.1 ± 0.83.0 ± 0.70.2853
PROCAM risk, mean ± SD12.14±11.33%11.45±9.10%0.7425
Event (infarction, stroke, etc.), n (%)14 (5.4%)80 (23.9%)< 0.0001
Cardiovascular death, n (%)1 (0.4%)11 (3.5%)0.0158
Follow-up time (months) (min. - max.)46 (0 - 130)43 (0 - 124)0.5305